- Trials with a EudraCT protocol (2,185)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6)
2,185 result(s) found for: sanofi.
Displaying page 1 of 110.
EudraCT Number: 2015-005189-48 | Sponsor Protocol Number: MPS01 | Start Date*: 2015-11-17 |
Sponsor Name:Sanofi Pasteur SA | ||
Full Title: Safety and Immunogenicity of Sanofi Pasteur Meningococcal (Groups A and C) Polysaccharide Vaccine versus Lanzhou Institute of Biological Products Meningococcal (Groups A and C) Polysaccharide Vacci... | ||
Medical condition: Meningococcal Disease | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2017-002988-18 | Sponsor Protocol Number: EFC15068 | Start Date*: 2018-11-26 | |||||||||||
Sponsor Name:Sanofi-Aventis Recherche & Développement | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis | |||||||||||||
Medical condition: Giant Cell Arteritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) AT (Prematurely Ended) DK (Completed) HU (Completed) FR (Completed) SE (Prematurely Ended) EE (Prematurely Ended) ES (Prematurely Ended) NL (Prematurely Ended) PT (Completed) SI (Completed) BE (Prematurely Ended) HR (Completed) GB (GB - no longer in EU/EEA) NO (Completed) FI (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005184-16 | Sponsor Protocol Number: IPV26 | Start Date*: 2015-11-17 |
Sponsor Name:Sanofi Pasteur SA | ||
Full Title: Immunogenicity and Safety of Fractional Booster Dose of sanofi pasteur’s Inactivated Poliomyelitis Vaccine (IMOVAX Polio) Administered Intradermally versus Full Booster Dose of Inactivated Poliomye... | ||
Medical condition: Poliomyelitis | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2015-005183-42 | Sponsor Protocol Number: IPV25 | Start Date*: 2015-11-17 |
Sponsor Name:Sanofi Pasteur SA | ||
Full Title: Immunogenicity and Safety of Fractional Doses of Sanofi Pasteur’s Inactivated Poliomyelitis Vaccine (IMOVAX Polio™) Administered Intradermally versus Full Doses of Inactivated Poliomyelitis Vaccine... | ||
Medical condition: Poliomyelitis | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2015-005185-34 | Sponsor Protocol Number: IPV29 | Start Date*: 2015-11-19 |
Sponsor Name:Sanofi Pasteur China | ||
Full Title: Safety study of IMOVAX Polio in selected cities in China, an observational post marketing study | ||
Medical condition: Poliomyelitis | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2016-001964-13 | Sponsor Protocol Number: HAF85 | Start Date*: 2016-05-06 |
Sponsor Name:Sanofi Pasteur Korea Ltd | ||
Full Title: Regulatory Post-Marketing Surveillance (PMS) Study for AVAXIM 160U (Hepatitis A Vaccine) | ||
Medical condition: Hepatitis A | ||
Disease: | ||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2015-005186-23 | Sponsor Protocol Number: IPV34 | Start Date*: 2015-11-19 |
Sponsor Name:Sanofi Pasteur China | ||
Full Title: Large scale safety study of IMOVAX Polio in selected cities in China, an observational post marketing study | ||
Medical condition: Poliomyelitis | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2004-003809-25 | Sponsor Protocol Number: L-9134 | Start Date*: 2004-12-20 |
Sponsor Name:Sanofi-Synthelabo Co. Ltd. | ||
Full Title: Comparison of the efficacy and tolerability of drotaverine 80 mg or ibuprofen 400 mg administered alone with their combination for the treatment of primary and secondary dysmenorrhea | ||
Medical condition: A NO-SPA és az ibuprofen kombinációja elfogadott és Magyarországon gyakran használták a nőgyógyászati gyakorlatban sok évvel ezelőtt. A kombináció használatával kapcsolatos súlyos mellékhatásról ne... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: HU (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-001707-53 | Sponsor Protocol Number: CYD13 | Start Date*: 2014-05-26 |
Sponsor Name:Sanofi Pasteur SA | ||
Full Title: Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America | ||
Medical condition: Prevention of symptomatic dengue disease | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2011-005698-21 | Sponsor Protocol Number: EFC11570 | Start Date*: 2013-03-05 | |||||||||||
Sponsor Name:sanofi-aventis Recherche & Développement | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recentl... | |||||||||||||
Medical condition: Acute coronary syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) SE (Completed) BE (Completed) NO (Completed) EE (Completed) LT (Completed) HU (Completed) ES (Completed) CZ (Completed) LV (Completed) DE (Completed) IT (Completed) BG (Completed) FI (Completed) AT (Completed) PT (Completed) DK (Completed) NL (Completed) PL (Completed) SK (Completed) SI (Completed) HR (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005191-18 | Sponsor Protocol Number: HAF78 | Start Date*: 2015-11-19 |
Sponsor Name:Sanofi Pasteur SA | ||
Full Title: Immunogenicity and Safety of Sanofi Pasteur’s AVAXIM 80U Pediatric Vaccine Administered in Healthy Adolescents, Children and Toddlers in People’s Republic of China Followed by a Booster Dose 6 Mont... | ||
Medical condition: Hepatitis A | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2015-005197-38 | Sponsor Protocol Number: TD9707-LT | Start Date*: 2015-11-19 |
Sponsor Name:Sanofi Pasteur Limited | ||
Full Title: Six-Month, One-Year, Three-Year, Five-Year and Ten-Year Data on the Long-Term Immunogenicity of Td-mIPV, Tdap-vIPV, Td, aP and Tdap in Adolescents and Adults | ||
Medical condition: Pertussis Tetanus Diphtheria | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2005-002789-12 | Sponsor Protocol Number: U05-PnPS-403 | Start Date*: 2005-09-28 |
Sponsor Name:Sanofi Pasteur MSD S.N.C | ||
Full Title: A double blind comparative and randomised study in healthy adults of the safety, tolerability, and immunogenicity of PNEUMOVAX®II formulated with either all new process polysaccharides or all curre... | ||
Medical condition: Prevention of invasive pneumococcal disease (IPD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-004660-37 | Sponsor Protocol Number: LACAC_L_03732 | Start Date*: 2015-03-25 | |||||||||||
Sponsor Name:Sanofi | |||||||||||||
Full Title: Monocentric Study, Phase III, for Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower | |||||||||||||
Medical condition: Healthy volunteers (hygiene) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004662-26 | Sponsor Protocol Number: LACAC_L_04298 | Start Date*: 2015-03-25 | |||||||||||
Sponsor Name:Sanofi | |||||||||||||
Full Title: Safety Dermatological Evaluation: genital Mucosa Irritation - Product tested: Dermacyd PH_DETINLYN Sweet Flower. | |||||||||||||
Medical condition: Healthy volunteers (hygiene) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004661-25 | Sponsor Protocol Number: LACAC_L_03735 | Start Date*: 2015-03-25 | |||||||||||
Sponsor Name:Sanofi | |||||||||||||
Full Title: Monocentric Study, Phase III, for Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Tangerina Mix | |||||||||||||
Medical condition: Healthy volunteers (hygiene) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004659-30 | Sponsor Protocol Number: PKM6270 | Start Date*: 2015-03-17 |
Sponsor Name:sanofi-aventis | ||
Full Title: Four-week, open-label, multicenter, randomized, parallel-group study to investigate the pharmacokinetics, safety, tolerability and the effects on leak point pressure of 2 oral doses of alfuzosin (0... | ||
Medical condition: Urinary Bladder Neurogenic | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2014-004664-38 | Sponsor Protocol Number: LACAC_L_04304 | Start Date*: 2015-03-25 | |||||||||||
Sponsor Name:Sanofi | |||||||||||||
Full Title: Safety Dermatological Evaluation: genital mucosa irritation - Product tested: Dermacyd PH_DETINLYN Tangerine Mix. | |||||||||||||
Medical condition: Healthy volunteers (hygiene) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004666-14 | Sponsor Protocol Number: LACAC_L_04678 | Start Date*: 2015-03-25 | |||||||||||
Sponsor Name:Sanofi | |||||||||||||
Full Title: Safety Dermatological Evaluation: acceptability with pediatric follow up – Dermacyd Infantile LACAC_L_04678 | |||||||||||||
Medical condition: Healthy volunteers (hygiene) | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004663-20 | Sponsor Protocol Number: LACAC_L_04301 | Start Date*: 2015-03-25 | |||||||||||
Sponsor Name:Sanofi | |||||||||||||
Full Title: Safety Dermatological Evaluation: genital mucosa irritation - Product tested: Dermacyd PH_DETINBACK Sweet Flower | |||||||||||||
Medical condition: Healthy volunteers (hygiene) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.